Dolby Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Dolby Laboratories has a total shareholder equity of $2.5B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $3.2B and $641.6M respectively. Dolby Laboratories's EBIT is $277.5M making its interest coverage ratio -10.1. It has cash and short-term investments of $520.8M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -10.1x |
| Cash | US$520.82m |
| Equity | US$2.52b |
| Total liabilities | US$641.57m |
| Total assets | US$3.16b |
Recent financial health updates
No updates
Recent updates
Dolby Laboratories Remains Fully Valued On Slow Growth
Feb 07Dolby Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 01
Are Investors Undervaluing Dolby Laboratories, Inc. (NYSE:DLB) By 38%?
Jan 26Should You Investigate Dolby Laboratories, Inc. (NYSE:DLB) At US$78.28?
Dec 26Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Not Quite Adding Up
Dec 10Dolby Laboratories: Picture Improved, But Still A Bit Too Expensive
Nov 22Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns
Oct 28Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Sep 22Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital
Aug 22Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion
Aug 13We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)
Jul 26Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13Dolby Laboratories Sees Return To Growth Ahead
Jun 22Financial Position Analysis
Short Term Liabilities: DLB's short term assets ($1.3B) exceed its short term liabilities ($441.9M).
Long Term Liabilities: DLB's short term assets ($1.3B) exceed its long term liabilities ($199.7M).
Debt to Equity History and Analysis
Debt Level: DLB is debt free.
Reducing Debt: DLB has not had any debt for past 5 years.
Debt Coverage: DLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DLB has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/22 11:00 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/27 |
| Annual Earnings | 2024/09/27 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dolby Laboratories, Inc. is covered by 23 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Bright | Avondale Partners |
| Ishan Majumdar | Baptista Research |
| James Goss | Barrington Research Associates, Inc. |